- 會議活動
- 生醫轉譯研究中心
- 地點
國家生技研究園區C棟二樓C201國際會議廳(台北市11571南港區研究院路一段130巷99號)
- 演講人姓名
Dr. Carl-Henrik Heldin (Chairman of the Board for the Nobel Foundation)
- 活動狀態
確定
- 活動網址
The 3rd International Scientific Symposium on TGFβ Signaling in Cancer and Other Diseases will be held on April 6, 2023 at the C201 International Conference Hall in National Biotechnology Research Park (NBRP). We are very grateful to invite Dr. Carl-Henrik Heldin, the Chairman of the Board of the Nobel Foundation, as well as Dr. Paraskevi Heldin, Dr. Han-Chung Wu, Dr. James Chih-Hsin Yang, and Dr. Jung San Huang to serve as the keynote speakers.
As we know the multiple functions of transforming growth factor beta (TGF-β) come from its pleiotropic nature of signaling, which involves different TGF-β receptors, non-Smad pathways, and hyaluronan-CD44 signaling pathway. The dual extreme actions of TGF-β in cancer as tumor suppressor in early stages and as tumor promoter in late stage are yet originated from these different pathways. In this symposium, we will also discuss drug development in cancer and infectious diseases, as well as the mRNA technology, which has demonstrated its immense potential since COVID-19 pandemics for vaccine and drug development in infectious and other diseases. You are very welcome to join this event with us.
Time: 12:00-17:30, April 6, 2023 (Thursday) (Registration will start at 12:00)
Venue: C201 International Conference Hall, 2nd floor, Building C, National Biotechnology Research Park
(Address: No. 99, Aly 130, Sec. 1, Academia Rd., Nangang District, Taipei City 11571, Taiwan)
Organizer: Biomedical Translation Research Center, Academia Sinica; Excelsior Biopharma Inc.
Registration website: https://reurl.cc/Gepq2A
Transportation information: https://nbrp.sinica.edu.tw/pages/41
Language: English
Fee: Free of charge
Contact: Mr. Hsu, Tel: (02) 2653-2905 ext. 719